Baker Bros. Advisors LP Igm Biosciences, Inc. Transaction History
Baker Bros. Advisors LP
- $9.34 Billion
- Q3 2024
A detailed history of Baker Bros. Advisors LP transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Baker Bros. Advisors LP holds 4,092,310 shares of IGMS stock, worth $26.2 Million. This represents 0.72% of its overall portfolio holdings.
Number of Shares
4,092,310
Previous 4,090,316
0.05%
Holding current value
$26.2 Million
Previous $28.1 Million
140.88%
% of portfolio
0.72%
Previous 0.37%
Shares
12 transactions
Others Institutions Holding IGMS
# of Institutions
81Shares Held
20.7MCall Options Held
68KPut Options Held
52.2K-
Price T Rowe Associates Inc Baltimore, MD4.01MShares$25.7 Million0.01% of portfolio
-
Siren, L.L.C. New York, NY3.33MShares$21.3 Million2.75% of portfolio
-
Redmile Group, LLC San Francisco, CA3.07MShares$19.7 Million3.32% of portfolio
-
Goldman Sachs Group Inc New York, NY1.26MShares$8.06 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA890KShares$5.7 Million0.0% of portfolio
About IGM Biosciences, Inc.
- Ticker IGMS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,969,000
- Market Cap $185M
- Description
- IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...